LIFECORE BIOMEDICAL, INC. Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations
LIFECORE BIOMEDICAL, INC. (LFCR) reported Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations of $0 for the 12-month period ending 2021-05-30, per its 10-K filed 2021-07-29.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations · last filed 2021-07-29
- LIFECORE BIOMEDICAL, INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2021 was $0.00.
- LIFECORE BIOMEDICAL, INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- LIFECORE BIOMEDICAL, INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2019 was $25.00K, a 75.00% decline from fiscal 2018.
- LIFECORE BIOMEDICAL, INC. unrecognized tax benefits, reduction resulting from lapse of applicable statute of limitations for fiscal 2018 was $100.00K, a 68.65% decline from fiscal 2017.
| Period end | Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 12 month |
|---|---|
| 2021-05-30 | $0.00 10-K · filed 2021-07-29 |
| 2020-05-31 | $0.00 10-K · filed 2021-07-29 |
| 2019-05-26 | $25.00K 10-K · filed 2021-07-29 |
| 2018-05-27 | $100.00K 10-K · filed 2020-08-14 |
| 2017-05-28 | $319.00K 10-K · filed 2019-08-01 |
| 2012-05-27 | $240.00K 10-K · filed 2014-08-01 |
| 2011-05-29 | $153.00K 10-K · filed 2013-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |